Neighbourly Pharmacy Inc (TSX:NBLY)

C$ 18.54 0 (0%) Market Cap: 832.79 Mil Enterprise Value: 1.16 Bil PE Ratio: 0 PB Ratio: 1.42 GF Score: 64/100

Q2 2024 Neighbourly Pharmacy Inc Earnings Call Transcript
Oct 24, 2023

C$17.02 (-1.62%)

Earnings
Neighbourly Pharmacy Inc Annual Shareholders Meeting Transcript
Aug 01, 2023
Q1 2024 Neighbourly Pharmacy Inc Earnings Call Transcript
Aug 01, 2023

C$17.68 (+10.36%)

Earnings
Q4 2023 Neighbourly Pharmacy Inc Earnings Call Transcript
Jun 08, 2023

C$18.46 (-2.64%)

Earnings
Q3 2023 Neighbourly Pharmacy Inc Earnings Call Transcript
Feb 14, 2023

C$23.15 (-0.47%)

Earnings
Q2 2023 Neighbourly Pharmacy Inc Earnings Call Transcript
Oct 25, 2022

C$22.91 (+9.72%)

Earnings
Neighbourly Pharmacy Inc Annual Shareholders Meeting Transcript
Aug 02, 2022
Q1 2023 Neighbourly Pharmacy Inc Earnings Call Transcript
Aug 02, 2022

C$21.13 (-8.96%)

Earnings
Q4 2022 Neighbourly Pharmacy Inc Earnings Call Transcript
Jun 23, 2022

C$23.48 (+2.09%)

Earnings
Neighbourly Pharmacy Inc To Acquire Rubicon Pharmacies - M&A Call Transcript
Mar 10, 2022
Q3 2022 Neighbourly Pharmacy Inc Earnings Call Transcript
Feb 15, 2022

C$29.86 (-3.52%)

Earnings
Q2 2022 Neighbourly Pharmacy Inc Earnings Call Transcript
Oct 26, 2021

C$31.44 (+0.48%)

Earnings
Neighbourly Pharmacy Inc at Scotiabank Back to School Conference (Virtual) Transcript
Sep 14, 2021
Q1 2022 Neighbourly Pharmacy Inc Earnings Call Transcript
Aug 03, 2021

C$28.15 (-4.58%)

Earnings
Q4 2021 Neighbourly Pharmacy Inc Earnings Call Transcript
Jun 24, 2021

C$26.2

Earnings

Q3 2022 Neighbourly Pharmacy Inc Earnings Call Transcript

Feb 15, 2022 / 01:30PM GMT

Release Date Price: C$29.86 (-3.52%)

Transcript

Operator

Good morning, ladies and gentlemen, and welcome to the Neighbourly Pharmacy, Inc. Fiscal Year '22 Q3 Analyst Conference Call. (Operator Instructions) This call is being recorded on Tuesday, February 15, 2022. I would now like to turn the conference over to Mr. Chris Gardner. Please go ahead.

Chris Gardner

Neighbourly Pharmacy Inc. - CEO & Director

Thank you, operator, and good morning, everyone. Welcome to Neighbourly Pharmacy Inc.'s conference call to discuss our financial and operating results for the third quarter of 2022. I'm Chris Gardner, Neighbourly's Chief Executive Officer, and I'm joined this morning by Terri Smyth, our Chief Financial Officer.

Before we begin, I'd like to note that some of our comments today will contain forward-looking information and statements under applicable securities laws that reflect management's current views with respect to future events. Any such information and statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those projected in forward

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.